EMSLR and urinary bladder cancer: Next, we conducted a discovery study and the quality control, which was previously described,[22] and found that only rs62483508 in exon 1 of RP11‐132A1.4, named as Bladder cancer Cell Cytoplasm‐Enriched abundant transcript 4 (BCCE4), remained associated with a significantly decreased risk of bladder cancer (odds ratio (OR) = 0.81, 95% confidence interval (CI) = 0.70–0.94, Padj = 4.47 × 10−3; Tables S1 and S2, Supporting Information).